Loganathan, S., Klein, J., Haggag, A. Z., Shaw, A. A., Lawrence, T. E., Liu, M. S., Betha, M. R. (2025). A randomized, double-blind, three-arm, parallel group, phase 1 study to assess the pharmacokinetics, safety, and tolerability of PERT-IJS following a single dose of 420 mg intravenous infusion compared to the EU- and US-marketed drug product (pertuzumab; PERT) in healthy male volunteers.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e13009